U.S. RESEARCH ROUNDUP- Autozone, Domino's Pizza, Salesforce.com
02/03/2022 06:51
March 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Autozone, Domino's Pizza and Salesforce.com on
Wednesday.
HIGHLIGHTS
* Autozone Inc AZO.N : JP Morgan raises target price to $2,200 from $2,175
* Domino's Pizza Inc DPZ.N : RBC cuts target price to $525 from $550
* PMV Pharmaceuticals Inc PMVP.O : Oppenheimer raises to outperform from perform
* Salesforce.com Inc CRM.N : Piper Sandler cuts target price to $330 from $365
* Trex Company Inc TREX.N : JP Morgan cuts target price to $107 from $135
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order.
* 3M Co MMM.N : Melius Research cuts to hold from buy; cuts price target to $205 from $256
* Acadia Healthcare Company Inc ACHC.O : Credit Suisse raises target price to $78 from $74
* ADT Inc ADT.N : RBC cuts target price to $9 from $10
* AKA Brands Holding Corp AKA.N : Jefferies cuts target price to $18 from $22
* AKA Brands Holding Corp AKA.N : Piper Sandler cuts target price to $15 from $17
* Americold Realty Trust COLD.N : RBC cuts target price to $34 from $36
* Arcturus Therapeutics Holdings Inc ARCT.O : H.C. Wainwright cuts target price to $25
* Ardelyx Inc ARDX.O : Jefferies raises to buy from hold; raises PT to $5 from $1
* Aris Water Solutions Inc ARIS.N : Raymond James raises target price to $18 from $17
* Arlo Technologies Inc ARLO.N : Raymond James raises target price to $14 from $11
* Atea Pharmaceuticals Inc AVIR.O : JP Morgan cuts target price to $8 from $10
* Autozone Inc AZO.N : JP Morgan raises target price to $2,200 from $2,175
* Axsome Therapeutics Inc AXSM.O : SVB Leerink cuts target price to $50 from $65
* Bentley Systems Inc BSY.O : RBC cuts target price to $55 from $65
* BP BP.N : CFRA cuts target price to $32 from $37
* Broadmark Realty Capital Inc BRMK.N : Raymond James cuts target price to $11 from $12.50
* Brp Group Inc BRP.O : JP Morgan cuts target price to $35 from $42
* Chesapeake Utilities Corp CPK.N : RBC raises target price to $126 from $124
* Chevron Corp CVX.N : Raymond James raises target price to $173 from $150
* Chevron Corp CVX.N : RBC raises target price to $160 from $155
* Chevron Corp CVX.N : RBC raises target price to $160 from $155
* CTI Biopharma Corp CTIC.O : Needham raises target price to $8 from $5
* Cytokinetics Inc CYTK.O : JP Morgan cuts target price to $55 from $58
* Cytomx Therapeutics Inc CTMX.O : JP Morgan cuts target price to $9 from $10
* Domino's Pizza Inc DPZ.N : RBC cuts target price to $525 from $550
* Ehealth Inc EHTH.O : Evercore ISI cuts to in line rating; cuts price target to $15
* Endo International Plc ENDP.O : Piper Sandler cuts target price to $3 from $5
* Everi Holdings Inc EVRI.N : Jefferies raises target price to $33 from $30
* First Solar Inc FSLR.O : JP Morgan cuts target price to $67 from $83
* Forgerock Inc FORG.N : JP Morgan cuts target price to $36 from $41
* Forma Therapeutics Holdings Inc FMTX.O : Oppenheimer cuts target price to $49 from $60
* Goodrx Holdings Inc GDRX.O : Stephens cuts target price to $30 from $45
* Groupon Inc GRPN.O : Credit Suisse cuts target price to $29 from $38
* Health Catalyst Inc HCAT.O : RBC cuts target price to $35 from $66
* Health Catalyst Inc HCAT.O : SVB Leerink cuts target price to $48 from $64
* Healthcare Realty Trust Inc HR.N : Jefferies cuts target price to $32 from $38
* Healthcare Trust of America Inc HTA.N : Jefferies cuts target price to $36.50 from $38
* Hilton Grand Vacations Inc HGV.N : Jefferies raises target price to $69 from $62
* Hometrust Bancshares Inc HTBI.O : Piper Sandler cuts target price to $32 from $33
* Hormel Foods Corp HRL.N : JP Morgan raises target price to $48 from $46
* Hormel Foods Corp HRL.N : Piper Sandler raises target price to $49 from $48
* Inovio Pharmaceuticals Inc INO.O : RBC cuts target price to $5 from $6
* Interface Inc TILE.O : Raymond James cuts target price to $17 from $19
* Intra-Cellular Therapies Inc ITCI.O : Jefferies raises target price to $90 from $85
* Intra-Cellular Therapies Inc ITCI.O : SVB Leerink raises target price to $65 from $50
* Intra-Cellular Therapies Inc ITCI.O : SVB Leerink raises target price to $65 from $50
* J M Smucker Co SJM.N : Credit Suisse cuts target price to $130 from $140
* J M Smucker Co SJM.N : JP Morgan cuts target price to $143 from $144
* Jamf Holding Corp JAMF.O : RBC raises target price to $47 from $45
* Jamf Holding Corp JAMF.O : RBC raises target price to $47 from $45
* Karyopharm Therapeutics Inc KPTI.O : SVB Leerink cuts target price to $6 from $8
* Keycorp KEY.N : Piper Sandler cuts target price to $26 from $27
* Mirati Therapeutics Inc MRTX.O : Oppenheimer cuts target price to $125 from $155
* Montrose Environmental Group Inc MEG.N : Needham cuts target price to $60 from $84
* Nanostring Technologies Inc NSTG.O : JP Morgan cuts target price to $70 from $85
* Nektar Therapeutics NKTR.O : Jefferies cuts target price to $12 from $20
* Nelnet Inc NNI.N : Credit Suisse cuts target price to $92 from $96
* Olema Pharmaceuticals Inc OLMA.O : JP Morgan cuts target price to $30 from $47
* Outbrain Inc OB.O : Jefferies cuts target price to $16 from $18
* Paya Holdings Inc PAYA.O : BTIG cuts target price to $9 from $10
* Paya Holdings Inc PAYA.O : Credit Suisse cuts target price to $8.50 from $11
* Paya Holdings Inc PAYA.O : Raymond James cuts target price to $8 from $11
* Plug Power Inc PLUG.O : JP Morgan cuts target price to $38 from $42
* Plug Power Inc PLUG.O : RBC cuts target price to $33 from $39
* PMV Pharmaceuticals Inc PMVP.O : Oppenheimer raises to outperform from perform
* Quanterix Corp QTRX.O : JP Morgan cuts target price to $60 from $85
* Quanterix Corp QTRX.O : SVB Leerink cuts target price to $50 from $70
* Radius Global Infrastructure RADI.O : Credit Suisse cuts target price to $23 from $24
* Radius Global Infrastructure RADI.O : Raymond James cuts target price to $18 from $21
* Re/Max Holdings Inc RMAX.N : Jonesresearch starts with buy rating; $38 target price
* Regenxbio Inc RGNX.O : SVB Leerink cuts target price to $25 from $29
* Repay Holdings Corp RPAY.O : Credit Suisse cuts target price to $24 from $27
* Rhythm Pharmaceuticals Inc RYTM.O : Needham cuts target price to $40 from $45
* Rivian Automotive Inc RIVN.O : RBC cuts target price to $116 from $165
* Ross Stores Inc ROST.O : Jefferies cuts target price to $105 from $131
* S&P Global Inc SPGI.N : JP Morgan resumes with overweight rating and $480 target price
* Salesforce.com Inc CRM.N : Piper Sandler cuts target price to $330 from $365
* Sarepta Therapeutics Inc SRPT.O : RBC raises target price to $150 from $145
* Semrush Holdings Inc SEMR.N : Jefferies cuts target price to $15 from $20
* Semrush Holdings Inc SEMR.N : JP Morgan cuts target price to $20 from $26
* Semrush Holdings Inc SEMR.N : Piper Sandler cuts target price to $20 from $24
* Seres Therapeutics Inc MCRB.O : Jefferies cuts target price to $13 from $19
* Seres Therapeutics Inc MCRB.O : Oppenheimer cuts target price to $13 from $16
* Shift4 Payments Inc FOUR.N : Credit Suisse cuts target price to $80 from $90
* Shift4 Payments Inc FOUR.N : Piper Sandler cuts target price to $70 from $105
* Sofi Technologies Inc SOFI.O : Credit Suisse cuts target price to $15.50 from $16.50
* Surgery Partners Inc SGRY.O : SVB Leerink raises target price to $65 from $63
* Target Corp TGT.N : JP Morgan raises target price to $290 from $262
* Tenet Healthcare Corp THC.N : Stephens raises target price to $98 from $91
* Thoughtworks Holding Inc TWKS.O : Credit Suisse cuts target price to $25 from $31
* Thoughtworks Holding Inc TWKS.O : RBC cuts target price to $31 from $36
* Trex Company Inc TREX.N : JP Morgan cuts target price to $107 from $135
* UWM Holdings Corp UWMC.N : Credit Suisse cuts target price to $5 from $6.50
* Village Farms International VFF.O : Alliance Global Partners cuts target to $17 from $20
* Workhorse Group Inc WKHS.O : BTIG cuts target price to $11 from $14
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Endo International
See all newsBrief: Endo International PLC Files For Offering Of Up To 31.1 Million Common Shares By The Selling Stockholders - SEC Filing
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes